PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

NCT01800305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pegylated rhEPO
DRUG: EPIAO®

Sponsor

Xiamen Amoytop Biotech Co., Ltd.